ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Merus NV

Merus NV (2GH)

41.40
0.00
( 0.00% )
Updated: 01:56:54
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
41.40
Bid
41.40
Offer
42.00
Volume
0.00
0.00 Day's Range 0.00
21.40 52 Week Range 58.50
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-4.1666666666743.2474319244.19451697DE
4-8.6-17.25051.540.411744.74603537DE
12-3.8-8.4070796460245.251.540.412747.17167127DE
26-6.8-14.107883817448.257.540.415948.57608533DE
5218.4802358.521.39999917344.34418355DE
15617.673.949579831923.858.51916742.00023485DE
26017.673.949579831923.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.0618 €
(72.63%)
1.35M
1UR1Bee Vectoring Technologies International Inc
0.0075 €
(36.36%)
250k
A6NAsana Inc
19.70 €
(34.93%)
4.98k
1SSNextech3d Ai Corp
0.0336 €
(33.33%)
22.5k
C62Chariot Limited
0.031 €
(29.17%)
3.5k
AXIAtos SE
0.0031 €
(-98.43%)
1.12B
M0YNMynaric AG
2.30 €
(-55.08%)
11.45k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.0031 €
(-98.43%)
1.12B
D7GNel ASA
0.2602 €
(-2.55%)
2.79M
TUI1Tui AG
8.46 €
(1.83%)
1.86M
TE9Teco 2030 ASA
0.0618 €
(72.63%)
1.35M
R9BDeFi Technologies Inc
3.215 €
(5.07%)
990.18k

Discussion

View Full Feed
FinnMcMissile FinnMcMissile 18 seconds ago
It's stuck right now - can't seem to break that .003 barrier
HMBL
tw0122 tw0122 35 seconds ago
If it breaks $1.43 resistance solid then have $1.48- $2.03 next 
PWM
totffe totffe 35 seconds ago
Small buy moved this to 13. When volume picks up we will see 25 in a heart beat. With such a small SS this will move on air!!!!!
EMGE
getmoreshares getmoreshares 52 seconds ago
did you see the last two posts? SMH
BCAP
researcher59 researcher59 1 minute ago
Here's an interesting article in the WSJ about the market being wildly overvalued -

https://www.wsj.com/finance/stocks/stock-market-overvalued-forecasts-2025-e073e1d4?st=NMFNmq&reflink=desktopwebshare_permalink
skyrocketinsight skyrocketinsight 1 minute ago
Quote: AXXA contains 28 subsidiaries/companies there is no way in the real world That the value of 28 companies added together could amount to less than a penny. ($0.0008)

Have to agree with you there. Hope they catch the perpetrators who seemingly want to take this company down,.
AXXA
Newc Newc 1 minute ago
$cbtc (bitcoin mining) moved well with Bitcoin last time years ago. Will it move again this time when found?
CBTC
Fallingknife75 Fallingknife75 1 minute ago
Tequila shots with each touchdown the Lions scored

Ouch, how can you function this AM? Lol.
RDAR
pinkslipjunkie pinkslipjunkie 1 minute ago
Nice to see it hitting .0013 again...regardless of the volume and anybody who has anything to say about it...LOL
EMGE
threewheeler threewheeler 1 minute ago
GRLT started .0007s up bids stacking buy or chase out of trips
GRLT
TrendTrade2016 TrendTrade2016 1 minute ago
UPC 4 DOLLA BREAK
UPC
infamous infamous 1 minute ago
i did buy a few more at .0042
SFIO
georgie18 georgie18 2 minutes ago
Watching...was all out from .80 to $1.19...🥳
PWM
TJG TJG 2 minutes ago
Everyone complaining about OTCN... he moved down stayed down and they still can not trade this properly... head scratching as to why someone needs to put a million shares on the ASK and then wonder why people buy the BID... To many Boobs here.
AFFU
richme richme 2 minutes ago
OOOO?
ZHUD
Starlost Starlost 2 minutes ago
You jumped on the bandwagon too?
HMBL
infamous infamous 2 minutes ago
its the thinnest ive seen so far on the ask side. SFIO
SFIO
Dead On Arrival Dead On Arrival 2 minutes ago
The move to the NAS was a travesty as it accomplished nothing but line the pockets of Gumby and the Vulcan. It sucked all the volatility out of the stock and let the tutes manipulate the price down.Over three years later we have zero coverage. It was done to make it easier for LPC and Gumby to sell
LWLG
glenn1919 glenn1919 2 minutes ago
GXAI......ESLA.....NVTS.....ATHEhttps://stockcharts.com/h-sc/ui?s=GXAI&p=D&yr=0&mn=2&dy=12&id=p84071410134
ESLA GXAI NVTS
threewheeler threewheeler 3 minutes ago
GRLT started .0007s up bids stacking buy or chase out of trips
GRLT
infamous infamous 3 minutes ago
chart shows that if this closes above .0076, then above .01 is a guarantee ....pretty much. SFIO
SFIO
Moonboy1 Moonboy1 3 minutes ago
Day trades
GXAI
solidgold solidgold 3 minutes ago
PPS is still frozen in space. Can we do anything?
NBRI

Your Recent History

Delayed Upgrade Clock